Collaborative Stage

Note 1: The results for the Oncotype DX test are expressed as a percentage Recurrence Score ranging from 0 to 100, with risk assessment in the categories of low, intermediate, and high.
Note 2: The results for the MammaPrint test are expressed as low risk for distant recurrence and high risk for distant recurrence.
Note 3: Code the score or results of the multigene signature assay recorded in CS Site-Specific Factor 22. Code the percentage score for Oncotype DX if available in preference to the risk assessment. Code the risk assessment for MammaPrint.
Note 4: This information may not be available at diagnosis and may require follow-up with the physician.

Code	Description
001-100	Score of 000 - 100 (Actual score with leading zeroes to nearest whole percentage)
200	Low risk of recurrence (good prognosis)
205	OBSOLETE DATA CONVERTED V0203 See code 400 High risk of recurrence (poor prognosis)
300	Intermediate risk of recurrence
400	High risk of recurrence (poor prognosis)
988	Not applicable: Information not collected for this case (If this information is required by your standard setter, use of code 988 may result in an edit error.)
997	Test ordered, results not in chart
998	Test not done (test not ordered and not performed)
999	Unknown or no information Not documented in patient record

CS Site-Specific Factor 23
Multigene Signature Results